Navigation Links
NC State finds new nanomaterial could be breakthrough for implantable medical devices
Date:11/10/2008

A team of researchers led by North Carolina State University has made a breakthrough that could lead to new dialysis devices and a host of other revolutionary medical implants. The researchers have found that the unique properties of a new material can be used to create new devices that can be implanted into the human body including blood glucose sensors for diabetics and artificial hemo-dialysis membranes that can scrub impurities from the blood.

Researchers have long sought to develop medical devices that could be implanted into patients for a variety of purposes, such as monitoring glucose levels in diabetic patients. However, existing materials present significant problems. For example, devices need to be made of a material that prevents the body's proteins from building up on sensors and preventing them from working properly. And any implanted device also needs to avoid provoking an inflammatory response from the body that would result in the body's walling off the device or rejecting it completely.

Now a new study finds that nanoporous ceramic membranes may be used to resolve these issues. Dr. Roger Narayan an associate professor in the joint biomedical engineering department of NC State and the University of North Carolina at Chapel Hill led the research and says the nanoporous membranes could be used to "create an interface between human tissues and medical devices that is free of protein buildup."

The new research, published in a special issue of Biomedical Materials, is the first in-depth study of the biological and physical properties of the membranes. The study suggests that the human body will not reject the nanoporous ceramic membrane. Narayan adds that this could be a major advance for the development of kidney dialysis membranes and other medical devices whose development has been stalled by poor compatibility with human tissues. Narayan was also the lead researcher on the team that first developed these new
'/>"/>

Contact: Matt Shipman
matt_shipman@ncsu.edu
919-515-6386
North Carolina State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Obesity and the central nervous system -- the state of the art
2. University of Minnesota study refutes belief that black men have more aggressive prostate cancer
3. Iowa State University conference examines developing bioeconomy
4. University and state agencies to forecast local health effects of climate change
5. K-State Veterinary Lab routinely tests for bluetongue virus
6. New prostate cancer research findings
7. Iowa State professors genome research published in the latest issue of Science
8. Leading researchers to reveal comprehensive dos and donts for prostate cancer
9. K-State chemistry professor to receive Masao Horiba award
10. K-State sociologists use Department of Energy grant
11. NIH grants $33 M in institutional development awards to 3 states
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)... 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), the ... campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz will ... capacity to meet customer demand. Logo ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by Dr. ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... attention. But a study led by McGill researcher Sarah Kimmins ... equally important role in the health of their offspring. It ... diets and of food insecurity. The research focused on ... range of green leafy vegetables, cereals, fruit and meats. It ...
... SAN FRANCISCO, Calif. , Dec. 10, 2013 ... today announced preliminary results of an ongoing multi-center ... (mAb), which the company is developing as a ... disease or who were unfit for chemotherapy have ...
... Whitesides, Ph.D., and David Edwards, Ph.D., have been named ... joining 141 other innovators elected this year. ... to academic inventors who have demonstrated a prolific spirit ... tangible impact on quality of life, economic development, and ...
Cached Biology News:You are what your father eats 2KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 2KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 3KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 4KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 5Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors 2Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors 3
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... newly developed Bruton,s tyrosine kinase (BTK) inhibitor for ... results of these preclinical evaluations have been communicated ... feedback received from the Agency is supportive of ... preclinical work is required to begin a Phase ...
(Date:2/27/2015)... Australia , Feb. 27, 2015 Bionomics ... from the DisrupTOR-1 trial of BNC105 in patients with ... in Orlando, Florida . The data ... of the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and ...
(Date:2/27/2015)... 2015   PureTech , a science and technology ... products and technologies in the healthcare sector, announced today ... and Member of the Board of Directors of Sanofi, ... has been a pleasure to know Chris for many ... be working together more closely now," said Dr. ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) announced today ... present at the Leerink Swann,Solid Tumors Roundtable Conference ... on,Friday, May 9, 2008 at 11:10 a.m. EDT. ... through http://www.wsw.com/webcast/leerink15/kosn/ ., Interested parties may ...
... N.C., May 6 There are a lot of ... An organization,s,sales force must be involved with many of ... any successful re-launch effort,according to a study by benchmarking ... a sales force? Half of the companies that,participated in ...
... May 6 , WHAT: ABC,s Dancing with the Stars champion Drew Lachey ... a world leader in diabetes care, to ... diabetes awareness, Dancin, to Change Diabetes. The contest ... that help them stay active and healthy., ...
Cached Biology Technology:Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference 2Invigorated Sales Force Key to a Successful Re-Launch 2Dancing With the Stars' Drew Lachey and Novo Nordisk Launch Dancin' to Change Diabetes National Video Contest 2
Immunogen: Tissue / cell preparation. (Murine EHS laminin preparation) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human/Mouse APLP-1 MAb (Clone 354020) ENTREZ GeneID: 333...
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... and PDMS Stamps (3 PDMS micropatterned stamps with series ... x 10 mm or 200 um x 10 mm ...
Biology Products: